{"id":222,"date":"2024-12-13T14:10:10","date_gmt":"2024-12-13T13:10:10","guid":{"rendered":"https:\/\/www.chu-tours.fr\/mat\/?page_id=222"},"modified":"2025-01-08T11:08:58","modified_gmt":"2025-01-08T10:08:58","slug":"etudes-cliniques","status":"publish","type":"page","link":"https:\/\/www.chu-tours.fr\/mat\/etudes-cliniques\/","title":{"rendered":"Etudes cliniques"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"222\" class=\"elementor elementor-222\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ef21c38 e-flex e-con-boxed e-con e-parent\" data-id=\"ef21c38\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0767c51 elementor-widget elementor-widget-text-editor\" data-id=\"0767c51\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.23.0 - 15-07-2024 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<h3>Le Centre de R\u00e9f\u00e9rence Constitutif des Microangiopathies Thrombotiques participe aux protocoles de recherche acad\u00e9miques et industriels.<\/h3><p><span style=\"text-decoration: underline;\">Retrouvez ici les diff\u00e9rentes \u00e9tudes<\/span> :<\/p><p><b>Personalized<\/b> <b>Spacing<\/b><b> of <\/b><b>Eculizumab<\/b><b> Infusions <\/b><b>Based<\/b><b> on <\/b><b>Therapeutic<\/b> <b>Pharmacological<\/b><b> Monitoring (<\/b><b>EspacECU<\/b><b>) \u2013 Syndrome h\u00e9molytique et ur\u00e9mique atypique<\/b><\/p><ul><li>Pour plus d\u2019informations : <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04859608\" target=\"_blank\" rel=\"noopener\">https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04859608<\/a><\/li><\/ul><p><b>Efficacy<\/b><b> of a <\/b><b>Personalized<\/b> <b>Caplacizumab<\/b> <b>Regimen<\/b> <b>Based<\/b><b> on ADAMTS13 Activity Monitoring in <\/b><b>Adult<\/b> <b>aTTP<\/b><b> (CAPLAVIE) \u2013 Purpura thrombotique <\/b><b>thrombocytop\u00e9nique<\/b><b> acquise<\/b><\/p><ul><li>Pour plus d\u2019informations : <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04720261\" target=\"_blank\" rel=\"noopener\">https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04720261<\/a><\/li><\/ul><p><b>French National <\/b><b>Cohort<\/b><b> MATRIX \u201c<\/b><b>Renal<\/b><b> and <\/b><b>Systemic<\/b> <b>Thrombotic<\/b> <b>Microangiopathy<\/b><b>\u201d (MATRIX)<\/b><\/p><ul><li>Pour plus d\u2019informations : <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05991245\" target=\"_blank\" rel=\"noopener\">https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05991245<\/a><\/li><\/ul><p><b>Systematic<\/b> <b>review<\/b><b> \u00ab\u00a0<\/b><b>Malignant<\/b><b> Hypertension and <\/b><b>Kidney<\/b> <b>Histology<\/b><b>\u00a0\u00bb<\/b><\/p><ul><li>Pour plus d\u2019informations : <a href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=510666\" target=\"_blank\" rel=\"noopener\"><u>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=510666<\/u><\/a><\/li><\/ul><p><b>\u00a0A New <\/b><b>Breath<\/b><b> for <\/b><b>Malignant<\/b><b> Hypertension: <\/b><b>Implementation<\/b><b> of the HAMA <\/b><b>Cohort<\/b><b> (HAMA) \u2013 Hypertension art\u00e9rielle maligne<\/b><\/p><ul><li>Pour plus d\u2019informations : <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03755726\" target=\"_blank\" rel=\"noopener\">https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03755726<\/a><\/li><\/ul><p><b>Atypical<\/b> <b>Hemolytic-Uremic<\/b><b> Syndrome (<\/b><b>aHUS<\/b><b>) <\/b><b>Registry<\/b><b> \u2013 Syndrome h\u00e9molytique et ur\u00e9mique atypique <\/b>(Alexion Pharmaceuticals, Inc)<\/p><ul><li>Pour plus d\u2019informations : <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01522183\" target=\"_blank\" rel=\"noopener\">https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01522183<\/a><\/li><\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Le Centre de R\u00e9f\u00e9rence Constitutif des Microangiopathies Thrombotiques participe aux protocoles de recherche acad\u00e9miques et industriels. Retrouvez ici les diff\u00e9rentes \u00e9tudes : Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU) \u2013 Syndrome h\u00e9molytique et ur\u00e9mique atypique Pour plus d\u2019informations : https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04859608 Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2026-04-15 11:35:18","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/www.chu-tours.fr\/mat\/wp-json\/wp\/v2\/pages\/222"}],"collection":[{"href":"https:\/\/www.chu-tours.fr\/mat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chu-tours.fr\/mat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chu-tours.fr\/mat\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chu-tours.fr\/mat\/wp-json\/wp\/v2\/comments?post=222"}],"version-history":[{"count":7,"href":"https:\/\/www.chu-tours.fr\/mat\/wp-json\/wp\/v2\/pages\/222\/revisions"}],"predecessor-version":[{"id":381,"href":"https:\/\/www.chu-tours.fr\/mat\/wp-json\/wp\/v2\/pages\/222\/revisions\/381"}],"wp:attachment":[{"href":"https:\/\/www.chu-tours.fr\/mat\/wp-json\/wp\/v2\/media?parent=222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}